Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells
Zaynab Fatfat, Maamoun Fatfat, Hala Gali-Muhtasib, Department of Biology, American University of Beirut, Beirut 1107 2020, Lebanon
Hala Gali-Muhtasib, Center for Drug Discovery, American University of Beirut, Beirut 1107 2020, Lebanon
Author contributions: Fatfat Z and Fatfat M reviewed the literature and drafted the manuscript; Gali-Muhtasib H initiated the idea and revised the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hala Gali-Muhtasib, PhD, Professor, Department of Biology, and Center for Drug Discovery, American University of Beirut, Bliss Street, Beirut 1107 2020, Lebanon. firstname.lastname@example.org
Received: February 27, 2021
Peer-review started: February 27, 2021
First decision: March 31, 2021
Revised: April 11, 2021
Accepted: June 18, 2021
Article in press: June 18, 2021
Published online: July 24, 2021